Reduced Bacteriophage T7 Infectivity of Gentamicin Treated Escherichia
Total Page:16
File Type:pdf, Size:1020Kb
Journal of Experimental Microbiology and Immunology (JEMI) Vol. 21: 46 – 51 Copyright © July 2017, M&I UBC Reduced Bacteriophage T7 Infectivity of Gentamicin Treated Escherichia Coli UB1005 Is Likely Not a Result of Treatment- Induced Release of Cellular Factors Into The Culture Supernatant Manveer Nagra, Rachel Miller, Freddy Francis Department of Microbiology & Immunology, University of British Columbia Pre-treatment of Escherichia coli UB1005 with sub-lethal concentrations of gentamicin has been shown to reduce the infectivity of Bacteriophage T7. However, levels of infectivity has been shown to increase after a wash following antibiotic treatment. Thus we investigated the cause for the decreased infection of Bacteriophage T7 in Escherichia Coli UB1005 after treatment with a sub-lethal concentration of gentamicin. We hypothesized that treatment with sub inhibitory concentrations of gentamicin releases a cellular factor into the supernatant that serves as a decoy receptor to prevent T7 absorption. To test this hypothesis, we transferred supernatants of gentamicin treated UB1005 to untreated UB1005 and tested T7 infection. We observed that the transfer of supernatants from gentamicin treated UB1005 to untreated UB1005 did not reduce the infection of T7 in a double agar overlay assay. These data suggest that reduced T7 infectivity of UB1005 following gentamicin treatment is not due to a released, transferrable, cellular factor in the culture supernatant. Bacteriophages are viruses that infect bacteria and may substituting the divalent cations between LPS molecules cause bacterial cell rupture through lytic replication (1). Due that are critical in maintaining membrane integrity (7). The to their antibacterial properties, bacteriophages have been destabilizing effect on Gram-negative bacteria, including E. used to treat bacterial infections since the early 1900s, a coli, has been shown to induce the release of blebs of practice termed phage therapy (2). However, research in phospholipid bilayer from the outer membrane called outer phage therapy declined with the discovery of antibiotics membrane vesicles (OMVs) (8-10). Consequently, the LPS which was a more economical method to treat bacterial on the OMV surface may bind T7 phage and reduce levels infections. Today, excessive use of antibiotics has led to of phage adsorption as well as infection (10). Garcia- selective pressures that favor the evolution and spread of Gonzales et al. also suggested that T7 phage binding to the antibiotic resistant bacteria. Phage therapy can provide a OMV LPS or soluble LPS might lead to ejection of phage practical alternative to treating multi-drug resistant bacterial genome, essentially inactivating some of the virus (3). infections. However, since phage therapy is not well However, Hardman et al observed that when E. coli studied, further research is required to understand the UB1005 was suspended in minimal (M9) media with factors that might limit its clinical use. One important solubilized LPS prior to T7 infection, it did not show consideration would be to study the effectiveness of and decreased infectivity (6). This result may have been due to possible complications arising from simultaneous treatment the fact that gentamicin treatment of E. coli does not induce with antibiotics and phage therapy. a significant release of LPS (11). Furthermore, when Bacteriophage T7 belongs to the Podoviridae family and gentamicin treated E. coli were washed prior to infection has a polyhedral head, a simple tail, and one piece of double with T7, phage infectivity increased compared to that of stranded DNA transcript (1). T7 phage primarily infects non-treated bacteria, and suggested a factor present in the Escherichia coli (E. coli) that has a rough culture supernatant that has a protective effect from lipopolysaccharide (LPS) rich surface (3). T7 phage infection, that when removed increases susceptibility to undergoes lytic replication and produces progeny virus infection. These studies suggest that an alternative soluble particles within 12 to 25 minutes at ideal incubation factor in the cell-free media of gentamicin treated cells may temperatures (3, 4). It is postulated that the viral particle tail be responsible for the observed decrease in T7 infectivity adheres to the bacterial cell surface LPS prior to injecting (6). its DNA into the host (3). In vitro, studies have shown that In this study, we tested whether the reduction in T7 phage the binding of viral particle to bacterial rough LPS is infectivity of E. coli UB1005 following pre-treatment with sufficient for the ejection of phage DNA and thus LPS has sub-lethal levels of gentamicin is due to a soluble, aqueous been recognized as the main receptor mediating phage factor released into the media. We hypothesized that a adsorption and subsequent infection (3). stress-induced transferrable aqueous factor released in Pre-treatment of E. coli with sub-lethal concentrations of gentamicin treated E. coli UB1005 culture was the causative aminoglycoside antibiotics such as kanamycin and agent for reduced T7 phage infectivity of antibiotic treated gentamicin has been shown to reduce the adsorption and bacteria. Contrary to our hypothesis, our data suggests that infectivity, respectively, of T7 phage (5, 6). These reduced bacteriophage T7 infectivity of gentamicin treated polycationic antibiotics destabilize bacterial cell walls by Undergraduate Research Article 46 Journal of Experimental Microbiology and Immunology (JEMI) Vol. 21: 46 – 51 Copyright © July 2017, M&I UBC E. coli is not a result of treatment-induced release of of 50 µL comprised of 2 µL of dNTPs, 4 µL of MgCl2, 5 µL of aqueous factors 10X PCR reaction buffer, 1 µL of Forward Primer T7 rpol Fwd, 1 µL of Reverse Primer T7 rpol Rev, 0.25 µL of Taq Polymerase, MATERIALS AND METHODS 35.75 µL of PCR grade water and 1 µL of template DNA, were set up for PCR. Following a 950 C 10 minute denaturation steps, 30 Minimum Inhibitory concentration (MIC) assay. M9 media was cycles of PCR were run. Each cycle was 5 minutes at 95 ºC used to culture E. coli strain UB1005 obtained from Hancock Lab. (denaturation), 30 seconds at 52 ºC (annealing), 30 seconds at 74 M9 media is a minimal media used to test stress factors on ºC (extension). The reaction was held at 4 ºC once the 30 cycles organisms growing in minimal (12). were completed. The PCR was run on a T100™ Thermal Cycler Preparation of M9 media. A stock solution of 10X M9 salts from Biorad. Two sets of primers were used; one targeting the rpol were prepared for storage. 60 g Na2HPO4, 30 g KH2PO4, 5 g NaCl, of the T7 phage to check for its presence, and the other targeting 10 g NH4Cl were dissolved in 1000 mL of distilled water. This the gp23 of the T4 phage to check for possible contamination of mixture was sterilized by autoclaving. A 1 M stock solution of the T7 phage isolate with T4 phage. The sequence (5’ to 3’ CaCl2 was prepared in a separate bottle and sterilize by orientation) of the primers used were as follows: T7 rpol:Fwd: autoclaving. The M9 media was prepared by mixing together 100 CGAGGGCTTAGGTACTGC, T7 rpol:Rev: mL of 10X M9 salts, 0.1 mL of 1 M of CaCl2, 50 mL of 10% GGTGAGGTGCGGAACTTC, T4gp23:Fwd: glucose, 10 mL of 0.1 M MgSO4, 50 mL of 10% casamino acids, 2 GCCATTACTGGAAGGTGAAGG, and T4gp23:Rev: mL if 10 mg/ mL vitamin B1, 2 mL of 10 mg/mL tryptophan and TTGGGTGGAATGCTTCTTTAG 790 mL of deionized water. The mixture was autoclaved and stored The amplicons from the reaction were run on a 1% agarose gel. on lab bench. 0.5 g of agarose was mixed in 50 mL of TAE buffer and heated Preparation of gentamicin stock from gentamicin sulphate. using a microwave. When the solution was thoroughly mixed, it 0.5 g of gentamicin sulphate was added to 10 mL of sterile H2O was allowed to cool to approximately 60 ºC prior to the addition of and dissolved by shaking. A 0.22 µm syringe filter was primed by 4 µL of SYBR Safe. The gel was poured in a cassette and allowed drawing 5 mL of sterile H2O, which was subsequently discarded. to cool. 9 µL of the PCR reaction was mixed with 1 µl of 10X The gentamicin solution was filter sterilized using the primed 0.22 loading buffer and loaded on the gel. 10 µL of the GeneRuler™ 1 µm filter. This stock concentration was stored in -20 0C and used Kb plus was used as a scale for the molecular bands. The gel was to make further dilutions of working concentrations. run at 110 volts for 35 minutes. Minimum Inhibitory Concentration Assays. The minimum Phage bottom agar and Phage top agar. Phage bottom agar inhibitory concentration of gentamicin for E. coli strain UB1005 (PBA) was a 1.5% M9 agar that was used for the base. Phage top grown in minimal M9 media was determined by growing the cells agar (PTA) was a 0.75% M9 agar that is used for the phage plaque in a 96 well plate Corning™ Costar™ TC-Treated 96 well overlay assay. The M9 media was prepared and the appropriate polypropylene plates (Cat. No. CLS3790) using multiple amount of agar was added and autoclaved. The mixture was cooled concentrations of gentamicin. The range of gentamicin and poured into sterile petri plates. concentrations used was from 10 µg/mL to 0 µg/mL. An overnight Phage titer plaque assay. An overnight culture of the E. coli culture of E. coli strain UB1005 grown in M9 media was inoculated strain UB1005 was set up in 5 mL of M9 media. The culture was at 1:100 dilution and incubated in 37 ºC. The cells were grown until seeded at a 1:100 dilution in the required amount of M9 media.